Medicine Supply Notification: Fluticasone 125microgram / Salmeterol 25microgram (Combisal®) pressurised metered dose inhaler (pMDI)

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Fluticasone 125microgram / Salmeterol 25microgram (Combisal®) pressurised metered dose inhaler (pMDI).

MSN/2022/065

Tier 2 – medium impact

Date of issue 3rd August 2022

  • Fluticasone 125microgram / Salmeterol 25microgram (Combisal®) pressurised metered dose inhaler (pMDI) is out of stock until late-September 2022.
  • Alternative brands of fluticasone 125microgram with salmeterol 25microgram inhalers (pMDI) remain available.
  • A Serious Shortage Protocol (SSP) was issued on 22/07/2022.

A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.

DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.

The Tool also details any changes to resupply dates and updates to the entries.

To access the Tool you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

Capture healthcare advisory work not being covered by Pharmacy First to inform our negotiations with Government and NHS.

Click Here